Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness involves smaller hair follicles, larger oil glands, and other tissue changes, but not major blood supply issues.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

The pseudo 'fringe sign' can also appear in frontal fibrosing alopecia, not just in traction alopecia, showing that this condition may be more common than thought.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

FFA patients have fewer melanocytes and thinner skin compared to others.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

A hemodialysis patient's hair loss was caused by the drug tinzaparin but stopped after switching to a different drug.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

Inflammation, possibly triggered by a specific bacteria and activated by UV radiation, may contribute to male pattern baldness.

Hair loss on the lower legs is common in middle-aged men, usually harmless, and doesn't need treatment.

Congenital triangular alopecia can occur outside the typical fronto-temporal region.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

Hair loss in androgenic alopecia may be linked to increased local androgen activities, but not to estrogen levels.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Sunscreen particles were not found in inflamed or fibrotic areas of skin in FFA patients, suggesting no direct link to the disease.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

A girl's hair loss was found to be caused by both a hair-pulling disorder and another hair loss condition.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

The child was diagnosed with cutaneous leishmaniasis.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Hair loss in Androgenetic Alopecia is not caused by damage to follicular stem cells.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

CTE can distort results in hair growth trials, so exclude it carefully.

Isotretinoin at low doses effectively treats facial papules in frontal fibrosing alopecia.

Eosinophilic infiltrate is not a reliable indicator for diagnosing chronic alopecia areata.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

Hair loss in both Androgenetic Alopecia and Alopecia Areata is often accompanied by inflammation around hair follicles, but the location and severity of this inflammation varies.